One key finding was that patients classified as Very High Risk (VHR) under the 2018 ACC/AHA cholesterol guideline faced significantly greater threats when combined with prediabetes. This underscores the heightened vulnerability of this group to major adverse cardiovascular events.
The study emphasizes that precision in risk stratification allows clinicians to identify high-risk populations more accurately. This targeted approach ensures that patients receive interventions tailored to their specific needs, improving the chances of better outcomes.
Ultimately, this research supports the critical need for personalized treatment strategies. By focusing on those at greatest risk, healthcare providers can not only enhance patient care but also significantly reduce the burden of cardiovascular disease.
Source: www.ahajournals.org/doi/full/10.1161/JAHA.124.037492
